Indication
Vertinor is indicated in the treatment of Meniere's disease and Meniere-like syndromes are characterized by attacks of vertigo, tinnitus and/or progressive loss of hearing, usually accompanied by nausea and vomiting.
Dosage & Administration
The usual initial dose: 8 mg to 16 mg Betahistine Dihydrochloride three times daily taken preferably with meals.
Maintenance dose: Up to 48 mg Betahistine Dihydrochloride daily have been recommended.
Dose adjustment for Hepatic and renal impaired patients
Renal impairment: There is no data available for patients with renal impairment.
Hepatic impairment: There is no data available for patients with hepatic impairment.
Precautions
Caution should be exercised in patients with bronchial asthma and pepticulcer.
Use in special group
In Pregnancy
The safety of Betahistine in human pregnancy has not been completely established, although there is no known teratogenic effect in animals. A careful assessment of potential benefit should be made before prescribing Betahistine in pregnancy.
In lactation
Betahistine is excreted in the breast milk of nursing mother in concentrations similar to those found in plasma. Toxicity to the neonate at these concentrations is not known.
Usage in Pediatric patient
Betahistine is not recommended for use in children.
